Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.49 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.49 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 6/20 | 0.48 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.48 |
| ▸ | DPP4 | P27487 | 3/20 | 0.48 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.46 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.45 |
| ▸ | NPY4R | P50391 | 2/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.43 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9826997 | 0.94 | ERAP2 (0.49) | ERAP2LNPEPERAP1DPP7DPP8 | |
| Hydrochloric Acid SCHEMBL9827159 | 0.94 | ERAP2 (0.49) | ERAP2LNPEPERAP1DPP7DPP8 | |
| SCHEMBL8811612 | 0.92 | DPP7 (0.55) | ERAP2LNPEPERAP1DPP7DPP8 | |
| SCHEMBL8811607 | 0.92 | DPP7 (0.55) | ERAP2LNPEPERAP1DPP7DPP8 | |
| SCHEMBL2734207 | 0.88 | ERAP2 (0.52) | ERAP2LNPEPERAP1DPP7DPP8 | |
| SCHEMBL27182927 | 0.85 | BIRC2 (0.47) | ERAP2LNPEPERAP1BIRC2ZDHHC7 | |
| SCHEMBL13496274 | 0.84 | ERAP2 (0.54) | ERAP2LNPEPERAP1DPP7DPP8 | |
| SCHEMBL5529776 | 0.84 | NOD1 (0.56) | DPP7DPP8DPP9DPP4GNAI3 | |
| SCHEMBL15723448 | 0.84 | BIRC2 (0.51) | ERAP2LNPEPERAP1DPP7DPP8 | |
| SCHEMBL12992681 | 0.84 | DPP7 (0.50) | DPP7DPP8DPP9DPP4GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088757-B2 | Betulinol derivatives as anti-cancer agents | BIORINGS LLC (US) | 2012-01-03 | — | — | US | disclosed |
| US-20090176753-A1 | Betulinol derivatives as anti-cancer agents | SAXENA RESEARCH, LLC | 2009-07-09 | — | — | US | disclosed |
| US-20080286291-A1 | Betulinol Derivatives as Anti-Hiv Agents | SAXENA RESEARCH, LLC | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176753-A1 | Betulinol derivatives as anti-cancer agents | BET1, BRDT, BRCA1 | ERAP2 4039/4885LNPEP 3532/4885ERAP1 3295/4885 |
| US-20080286291-A1 | Betulinol Derivatives as Anti-Hiv Agents | BET1, NFATC1, CD4 | ERAP2 3294/4885LNPEP 1497/4885ERAP1 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.